Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation

Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis

(2014) Joanne C Masterson et al.   GUT

Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation

(2013) M Zaeem Cader et al.   GUT

CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis

(2013) I Moshkovits et al.   Mucosal Immunology

The role of pattern recognition receptors in intestinal inflammation

(2013) M Fukata et al.   Mucosal Immunology

The Receptor LMIR3 Negatively Regulates Mast Cell Activation and Allergic Responses by Binding to Extracellular Ceramide

(2012) Kumi Izawa et al.   IMMUNITY

Ly6Chi Monocytes in the Inflamed Colon Give Rise to Proinflammatory Effector Cells and Migratory Antigen-Presenting Cells

(2012) Ehud Zigmond et al.   IMMUNITY

Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor

(2012) Chigusa Nakahashi-Oda et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors

(2012) Yosuke Kurashima et al.   Nature Communications

Colonic Eosinophilic Inflammation in Experimental Colitis Is Mediated by Ly6Chigh CCR2+ Inflammatory Monocyte/Macrophage-Derived CCL11

(2011) A. Waddell et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: Mouse CD300f (CMRF-35-Like Molecule-1) Recognizes Outer Membrane-Exposed Phosphatidylserine and Can Promote Phagocytosis

(2011) S.-C. Choi et al.   JOURNAL OF IMMUNOLOGY

Inflammatory Bowel Disease

(2010) Arthur Kaser et al.   Annual Review of Immunology

Essential role for mast cell tryptase in acute experimental colitis

(2010) M. J. Hamilton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Signaling at Purinergic P2X Receptors

(2008) Annmarie Surprenant et al.   Annual Review of Physiology